Among adults with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism, intermittent calorie restriction leads to larger decreases in body fat and blood sugar levels than continuous calorie restriction, but the difference is not statistically confirmed.
See the scientific wording
In adults with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism, intermittent calorie restriction is associated with greater reductions in fat mass and glycosylated hemoglobin compared to continuous calorie restriction, though these differences were not statistically significant.
Very strong evidence
Randomized trialsOne good-quality study supports this claim.
What the research says
1 study reviewedSupporting (1)
Randomized Controlled TrialHuman2025
The study found that eating very few calories two days a week might help people with fatty liver and high blood sugar lose a bit more fat and lower blood sugar a little more than eating fewer calories every day—but the difference wasn't big enough to be 100% sure. The claim says the same thing, so the study supports it.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When a person eats very little food on certain days, the liver switches to burning stored fat for energy. This reduces fat buildup in the liver and improves how well the body responds to insulin, which lowers blood sugar levels over time.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Among adults with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism, intermittent calorie restriction leads to larger decreases in body fat and blood sugar levels than continuous calorie restriction, but the difference is not statistically confirmed.
Mechanism
1 studyWhen people eat very little on certain days, their liver starts burning fat instead of sugar. This clears fat from the liver and makes the body better at using insulin to lower blood sugar. Over time, this reduces both liver fat and overall body fat, and lowers the amount of sugar stuck to hemoglobin.
When a person eats very little food on certain days, the liver switches to burning stored fat for energy. This reduces fat buildup in the liver and improves how well the body responds to insulin, which lowers blood sugar levels over time.
Prolonged fasting periods trigger a shift in hepatic metabolism from glucose utilization to fatty acid oxidation
Increased fatty acid oxidation reduces intrahepatic lipid accumulation and decreases diacylglycerol-mediated inhibition of insulin signaling
Reduced hepatic insulin resistance enhances suppression of hepatic glucose production and improves peripheral glucose uptake
Sustained reduction in systemic glucose flux lowers glycation of hemoglobin
Energy deficit during fasting periods promotes lipolysis in adipose tissue, increasing free fatty acid mobilization and subsequent fat mass reduction
Evidence from Studies
Supporting (1)
Community contributions welcome
Intermittent versus Continuous Calorie Restriction for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Clinical Trial.
The study found that eating very few calories two days a week might help people with fatty liver and high blood sugar lose a bit more fat and lower blood sugar a little more than eating fewer calories every day—but the difference wasn't big enough to be 100% sure. The claim says the same thing, so the study supports it.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Intermittent vs Continuous Calorie Restriction on Fat Mass and HbA1c in Adults with MASLD and Impaired Glucose Metabolism
Population: Adults diagnosed with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism; Intervention: Intermittent calorie restriction; Comparator: Continuous calorie restriction; Outcomes: Change in fat mass and glycosylated hemoglobin; Duration: Minimum 12 weeks.
Double-Blind Randomized Controlled Trial Comparing Intermittent and Continuous Calorie Restriction on Fat Mass and HbA1c in Adults with MASLD and Impaired Glucose Metabolism
Population: Adults with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism; Intervention: 16:8 intermittent fasting; Comparator: Daily 20% calorie reduction; Outcomes: Change in fat mass (DXA) and HbA1c at 24 weeks; Duration: 24 weeks; Randomization: Stratified by baseline HbA1c and BMI; Blinding: Outcome assessors blinded.
Prospective Cohort Study Comparing Long-Term Changes in Fat Mass and HbA1c in Adults with MASLD Following Intermittent vs Continuous Calorie Restriction
Population: Adults with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism; Exposure: Self-selected intermittent or continuous calorie restriction; Comparator: Group assignment based on dietary adherence; Outcomes: Annual changes in fat mass and HbA1c over 3 years; Duration: 3 years.
Cross-Sectional Analysis of Fat Mass and HbA1c Levels in Adults with MASLD Following Intermittent or Continuous Calorie Restriction
Population: Adults with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism; Exposure: Current dietary pattern (intermittent vs continuous restriction); Outcomes: Measured fat mass and HbA1c at one time point; Duration: Single assessment.
Case Report of Fat Mass and HbA1c Changes in an Individual with MASLD Following Switch from Continuous to Intermittent Calorie Restriction
Population: Single adult with metabolic dysfunction-associated steatotic liver disease and abnormal glucose metabolism; Intervention: Transition from continuous to intermittent calorie restriction; Outcomes: Changes in fat mass and HbA1c over 6 months; Duration: 6 months.